Line between patent-protectable new medical indications and ineffective dietary supplements
This case (17 Ob 35/09k - 2 February 2010) concerned the infringement of a "Swiss-type" claim: "The use of an isoflavone phyto-oestrogen extract of soy or clover, for the manufacture of a medicament for administration in unit dosage form for the treatment of pre-menstrual syndrome, symptoms associated...